简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
E Fund China Science and Technology Innovation Board 50 Component ETF
E Fund China Science And Technology Innovation Board 50 Component ETF (588080) rises 3.39%, with a scale increase of 1.901 billion yuan over the past week
Tags:
ETF
588080.SH
E Fund China Science and Technology Innovation Board 50 Component ETF
2026-06-17
ETF Financing Ranking | E Fund China Science and Technology Innovation Board 50 Component ETF (588080) had a net financing buy-in of CNY 66.03 million, ranked in the top 2 among comparable funds-20260608
Tags:
E Fund China Science and Technology Innovation Board 50 Component ETF
588080.SH
2026-06-09
ETF Financing Ranking | E Fund China Science and Technology Innovation Board 50 Component ETF (588080) had a net financing buy-in of CNY 147 million on Jun 1, had leveraged funds with continuous inflow over 350.22 million the last 2 days
Tags:
E Fund China Science and Technology Innovation Board 50 Component ETF
588080.SH
NewTimeSpace
2026-06-02
E Fund China Science And Technology Innovation Board 50 Component ETF(588080) Rises 9.23% in Morning Trading, Aiming for Third Consecutive Gain
Tags:
ETF
588080.SH
E Fund China Science and Technology Innovation Board 50 Component ETF
2026-05-06
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App